Congo Ebola outbreak exploding, right on schedule… hospital workers flee


Ebola is overtaking the Democratic Republic of Congo, a nation that is also currently being ravaged by war and unrest. Some 100 militias control the area around Butembo, a city in the nation’s eastern region. Butembo is the epicenter of Congo’s Ebola outbreak, but it is also home to other dangers — especially for healthcare workers. As Economist notes, locals are known for being wary of health workers and distrusting them. Locals have even gone so far as to attack and kill medical staff. But perhaps there is a reason for that.

Ebola has been presented to us as a disease, but many experts have cautioned that this “virus” could actually be a weapon. There have already been reports of terrorist organizations attempting to use Ebola as a weapon — it is not hard to believe the United States government conspired to do the same.

Some experts have spoken out about the U.S. government’s secret “biological warfare research” in African countries that also just so happen to be Ebola hot spots, with some even suggesting that our own military is testing weaponized viruses on innocent people. While such theories are often lambasted as “conspiracy theories,” it isn’t really that hard to believe. The U.S. government has been testing biowarfare weapons on American citizens for decades — surely they have no qualms about doing it to anyone else.

Ebola: Epidemic or engineered?

If you follow the mainstream media, you’ve probably heard that Ebola comes from tainted bushmeat in West Africa. But what most of the media won’t say is that until 2013, Ebola had never been seen in West Africa. A  two-year-old boy in the remote village of Meliandou, Guinea was the first case. Scientists have never determined how he contracted it or where it came from.

What they do know is that Ebola somehow managed to travel 3,5000 kilometers across the African continent, and infect that little boy’s community — apparently, without infecting anyone else along the way.

Francis Boyle, a professor at the University of Illinois College of Law, has posited that the appearance of the virus in West Africa was no accident.

In an interview with SIA Novosti, he said, “U.S. government agencies have a long history of carrying out allegedly defensive biological warfare research at labs in Liberia and Sierra Leone. This includes the Centers for Disease Control and Prevention (CDC), which is now the point agency for managing the Ebola spill-over into the U.S.”

He added: “Why has the Obama administration dispatched troops to Liberia when they have no training to provide medical treatment to dying Africans? How did Zaire/Ebola get to West Africa from about 3,500km away from where it was first identified in 1976?”

The U.S. government’s patent on any and all forms of Ebola is also pretty suspicious.

Patenting pathogens

As Mike Adams, founder of Natural News and Brighteon.com, reports, the CDC was awarded a patent on the Ebola virus in 2010 — three years before Ebola “suddenly” appeared in West Africa.

Adams reports that the patent gives the government agency “ownership over all variants of Ebola which share 70% or more of the protein sequences described in the patent,” as well as “ownership over any and all Ebola viruses which are ‘weakened’ or ‘killed.'”

You can view the patent here.

Some experts have also posited that Ebola was originally developed for the Department of Defense as a bioweapon, and that it has been released in Africa for testing purposes. Journalist Jon Rappaport has also sounded the alarm on bioweapons testing in Africa.

We already know that the U.S. government is not above testing weapons and technology on unsuspecting innocents. Whether they’re doing it for profit, for defense purposes or purely for their own entertainment — who knows. But if one thing’s for certain, it’s that there’s more to the Ebola outbreak than meets the eye.

See more coverage of Ebola at Outbreak.news.

Sources for this article include:

Economist.com

TheGuardian.com

BusinessInsider.com

ScientificAmerican.com



Comments

RECENT NEWS & ARTICLES